DelistingJul 24, 2026, 04:42 PM
Standard BioTools Receives Nasdaq Delisting Notice
AI Summary
Standard BioTools Inc. received a notification from Nasdaq on July 22, 2026, indicating non-compliance with the minimum bid price requirement. The company's share price closed below $1.00 for 30 consecutive business days. Standard BioTools has 180 calendar days, until January 19, 2027, to regain compliance, with no immediate effect on its Nasdaq listing or trading. The company may be eligible for an additional 180-day period if it meets other listing standards and transfers to The Nasdaq Capital Market.
Key Highlights
- Received Nasdaq notice on July 22, 2026, for minimum bid price non-compliance.
- Share price closed below $1.00 for 30 consecutive business days.
- Has 180 calendar days, until January 19, 2027, to regain compliance.
- Listing and trading on Nasdaq Global Select Market continue uninterrupted.
- May be eligible for an additional 180-day period by transferring to Nasdaq Capital Market.
- Company intends to work toward restoring compliance within the timeframe.
Price Impact
More from LAB